Home › Funds › Stonepine Capital Management, LLC › CLRB

Stonepine Capital Management, LLC position in CLRB

CELLECTAR BIOSCIENCES INC · Health Care

Stonepine Capital Management, LLC reported holding 749,028 shares of CLRB (CELLECTAR BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.06% of its reported portfolio and ranking #22 among its reported holdings. Stonepine Capital Management, LLC has disclosed CLRB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)749.03K sh
Reported value held$1.38M
Portfolio Weight1.06%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's CLRB position evolved

Stonepine Capital Management, LLC first disclosed a stake in CLRB in Q2 2026 at 104,550 shares (US$291K). The position peaked in Q3 2026 at 749,028 shares, worth US$1.4M. Across 2 filings, Stonepine Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 749,028 shares valued at US$1.4M — an increase of 644,478 shares quarter over quarter.. Notable position changes include a 616% increase in Q3 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 104.55K $290.65K New
Q3 2026 749.03K $1.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLRB and 13F data

CLRB (CELLECTAR BIOSCIENCES INC) is a Health Care company. 21 other funds we track also report a position in CLRB — the largest reported positions include Caligan Partners LP (US$1.3M), Empery Asset Management, LP (US$527K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLRB

All CLRB fund holders →

FAQ

How long has Stonepine Capital Management, LLC held CLRB?

Stonepine Capital Management, LLC has disclosed CLRB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Stonepine Capital Management, LLC's current position in CLRB?

As of Q3 2026, Stonepine Capital Management, LLC holds 749.03K shares of CLRB (CELLECTAR BIOSCIENCES INC), valued at $1.38M, representing 1.06% of its reported portfolio and ranking #22.

Has Stonepine Capital Management, LLC been buying or selling CLRB?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC increased its position in CLRB. The position peaked in Q3 2026 at 749.03K shares.

Which other funds hold CLRB?

Other major institutional holders of CLRB include Caligan Partners LP, Empery Asset Management, LP, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.